Home Office data shows young Black males aged 10-17 had the highest rate of stop and search at 106.3 per 1,000 people, compared with 27.1 for their White counterparts
world3 days ago
The US Food and Drug Administration on Friday approved for the first time a pill to treat postpartum depression, a condition believed to affect around half a million women in the country every year.
The antidepressant drug, called zuranolone, is "the first oral medication indicated to treat postpartum depression (PPD) in adults," the FDA said in a statement.
"Until now, treatment for PPD was only available as an IV injection given by a health care provider in certain health care facilities," it added.
Dr Asima Ahmad, the chief medical officer at Carrot Fertility, a healthcare company in Menlo Park, California, said that "about one in eight women experience PPD symptoms after a recent live birth, and among those reporting symptoms, 75 per cent go untreated."
"These numbers are elevated for minority populations; 81 percent of Black women and 76 percent of Hispanic women said they would have liked to learn more about postpartum mental health before having children, compared to 70 percent of women overall," she said.
"In a time when we are seeing rising maternal mortality rates, and significant racial disparities in maternal outcomes, we need to focus on solutions, and that includes addressing postpartum depression."
The pill, specifically designed for postpartum depression, has been shown to work faster than other antidepressants and is designed to be taken only over a short two-week period.
Trials of the pill showed its side effects were less severe than other antidepressants currently in use, which can lead to sudden loss of consciousness, weight gain or sexual dysfunction, Ahmad said.
"Both the lower incidence of side effects and the short-term regimen, which could help some feel less stigma around having to use an antidepressant, could potentially improve compliance," she said.
Tiffany Farchione, head of psychiatry in the FDA's Centre for Drug Evaluation and Research, said postpartum depression is "a serious and potentially life-threatening condition in which women experience sadness, guilt, worthlessness — even, in severe cases, thoughts of harming themselves or their child."
"Having access to an oral medication will be a beneficial option for many of these women coping with extreme, and sometimes life-threatening, feelings," she said.
The pill will be marketed under the brand name Zurzuvae, and was developed by Massachusetts-based Sage Therapeutics.
According to the New York Times, the only other drug approved for postpartum depression is brexanolone, which was approved by the FDA in 2019 but requires a 60-hour intravenous infusion in a hospital, and costs $34,000.
No price has yet been announced for the new oral pill.
ALSO READ:
Home Office data shows young Black males aged 10-17 had the highest rate of stop and search at 106.3 per 1,000 people, compared with 27.1 for their White counterparts
world3 days ago
Palestinian Authority expresses hope that a ceasefire will bring stability to the region, especially in war-torn Gaza
world3 days ago
The ceasefire brings to a halt a war that has killed thousands in Lebanon and resulted in mass displacement on both sides of the border
world3 days ago
Since early Wednesday, traffic on the road leading to the main southern city of Sidon has been congested, as hundreds of displaced people returned to their homes following the truce
world3 days ago
Syria's state news agency reported four civilians and two soldiers were killed, and 12 people were wounded including children, women and workers in the Syrian Red Crescent
world3 days ago
Israel has acknowledged responsibility for the pager attacks in September that killed dozens of people and wounded thousand
world5 days ago
This travel-related case was associated with an ongoing outbreak of clade I mpox in central and eastern Africa, said the Public Health Agency of Canada
world6 days ago
Jordanian police had earlier cordoned off an area near the heavily policed embassy after gunshots were heard
world6 days ago